Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-14

FDA Approved: EPLERENONE — Original Application (Breckenridge Pharmaceutical, Inc.)

View source ↗

Summary

FDA approved Breckenridge Pharmaceutical's original ANDA for eplerenone (generic), a mineralocorticoid receptor antagonist used to treat heart failure and hyper…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • eplerenone (eplerenone)

Snippet

ORIG AP for EPLERENONE (EPLERENONE)